首页> 外文OA文献 >The impact of everolimus versus other rapamycin derivative-eluting stents on clinical outcomes in patients with coronary artery disease: A meta-analysis of 16 randomized trials

【2h】

The impact of everolimus versus other rapamycin derivative-eluting stents on clinical outcomes in patients with coronary artery disease: A meta-analysis of 16 randomized trials

机译：依维莫司与其他雷帕霉素衍生物洗脱支架对冠状动脉疾病患者临床结局的影响：一项16项随机试验的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zhang Yao-Jun; Zhu Lin-Lin; Bourantas Christos V.; Iqbal Javaid; Dong Sheng-Jie; Campos Carlos M.; Li Ming-Hui; Ye Fei; Tian Nai-Liang; Garcia-Garcia Hector M.; Serruys Patrick W.; Chen Shao-Liang;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The impact of everolimus versus other rapamycin derivative-eluting stents on clinical outcomes in patients with coronary artery disease: A meta-analysis of 16 randomized trials [J] . Yao-fun Zhang, Lin-Lin Zhu, Christos V. Bourantas Journal of cardiology . 2014,第3a4期

机译：依维莫司与其他雷帕霉素衍生物洗脱支架对冠状动脉疾病患者临床结局的影响：一项16项随机试验的荟萃分析
2. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: Final 3-year results of the SPIRIT clinical trials program (Clinical evaluation of the Xience v everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions) [J] . DangasG.D., SerruysP.W., KereiakesD.J., JACC. Cardiovascular interventions . 2013,第9期

机译：依维莫司洗脱支架与紫杉醇洗脱支架在冠状动脉疾病中的荟萃分析：SPIRIT临床试验计划的最终3年结果（Xience v依维莫司洗脱冠状动脉支架系统在从头开始治疗天然冠心病患者的临床评估动脉病变）
3. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial. [J] . Byrne RA, Kastrati A, Massberg S, Journal of the American College of Cardiology . 2011,第13期

机译：冠心病患者的生物可降解聚合物与永久聚合物药物洗脱支架以及依维莫司与西罗莫司洗脱支架：一项随机临床试验的3年结果。
4. Clinical efficacy and safety of native bio-absorbable polymer Rapamycin-eluting stent (Excel stent) for Chinese patients with coronary artery disease [C] . Yanmin Xu, Guangping Li, Li Yin, International Congress on Coronary Artery Disease . 2009

机译：生物可吸收聚合物雷帕霉素洗脱支架（Excel支架）对冠心病患者的临床疗效和安全性
5. Impact of Incident Cancer on Coronary Artery Disease-Related Concomitant Medication Adherence, Short-Term Health and Economic Outcomes Among Elderly Medicare Beneficiaries with Coronary Artery Diseas [D] . Chopra, Ishveen Kaur. 2017

机译：癌症对冠状动脉疾病的老年医疗保险受益人冠状动脉疾病相关的药物依从性，短期健康和经济结果的影响
6. Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients [O] . J. Elias, I. M. van Dongen, R. P. Kraak, 2017

机译：生物可吸收血管支架与金属依维莫司洗脱支架在冠状动脉疾病中的中期和长期安全性和有效性：包括5577例患者在内的7项随机对照试验的加权荟萃分析
7. TCT-837 Everolimus-eluting versus other rapamycin derivatives-eluting stents in patients with coronary artery disease: a meta-analysis of 16 randomized trials [O] . Zhang Yao-Jun, Bourantas Christos, Chen Shao Liang, 2013

机译：TCT-837依维莫司洗脱与其他雷帕霉素衍生物洗脱支架在冠心病患者中的应用：16项随机试验的荟萃分析

The impact of everolimus versus other rapamycin derivative-eluting stents on clinical outcomes in patients with coronary artery disease: A meta-analysis of 16 randomized trials

著录项

引文网络

相似文献

相关主题

期刊订阅